Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010

OBJECTIVES: To evaluate the impact of risk minimisation policies on the use of rosiglitazone-containing products and on glycaemic control among patients in Denmark and the UK. DESIGN, SETTING AND PARTICIPANTS: We used population-based data from the Aarhus University Prescription Database (AUPD) in n...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrenstein, V, Hernandez, R K, Ulrichsen, S P, Rungby, J, Lash, T L, Riis, A H, Li, L, Sørensen, H T, Jick, S S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787411/
https://www.ncbi.nlm.nih.gov/pubmed/24068766
http://dx.doi.org/10.1136/bmjopen-2013-003424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787411/
https://www.ncbi.nlm.nih.gov/pubmed/24068766
http://dx.doi.org/10.1136/bmjopen-2013-003424

Ejemplares similares